// App-Quantinova.ai

126.0 : Comparison of chemoradiotherapy (CRT) with carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or junctional cancer: Experience from the Princess Margaret Cancer Centre.

Researchers

Presenter

  • Hao-Wen Sim

Principal Investigators

  • Akina Natori

  • Charles Henry Lim

  • Di Maria Jiang

  • Eric Xueyu Chen

  • Geoffrey Liu

  • Gail Elizabeth Darling

  • Carol Jane Swallow

  • Savtaj Singh Brar

  • James D. Brierley

  • Jolie Ringash

  • Rebecca Wong

  • John Kim

  • Patrik Rogalla

  • Sara Hafezi-Bakhtiari

  • James Conner

  • Jennifer J. Knox

  • Raymond Woo-Jun Jang

  • Elena Elimova

Medical Centers

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Cancer Centre, University Health Network, Division of Medical Oncology and Hematology, Toronto, ON, Canada

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Department of Surgical Oncology, Princess Margaret Cancer Centre and Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada

  • University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Paclitaxel

  • Cisplatin

  • Adrucil injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved